EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Translational Application of Recombinant Humanized Type III Collagen in Facial Rejuvenation: A Randomized Controlled Trial

Zeyu Huang iD, Ruzhi Zhang iD, Minmin Sheng, Ting Tian, Bin Xu, Fang Wang, Danmin Liu

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70529 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Zeyu Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Changzhou First People's Hospital, Changzhou, China. Hauptthemen laut MEDLINE: Skin Aging, Rejuvenation, Cosmetic Techniques, Collagen Type III. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Skin aging is a common aesthetic concern that drives the demand for new therapeutic strategies. Lyophilized injectable recombinant humanized type III collagen (rhCol III) is an emerging biomaterial with promising regenerative potential; however, clinical data on its efficacy is limited. This study aimed to evaluate the safety and effectiveness of rhCol III in improving the signs of skin aging.

Methods

A total of 55 participants were enrolled in the study. Those in the treatment group received “water‐light” intradermal injections of the study product alongside their routine skincare regimen. The control group continued with the routine skincare regimen alone. Clinical efficacy was assessed after treatment using VISIA imaging, evaluations by professional dermatologists, and self‐assessments by the participants.

Results

Of the 52 participants who completed the follow‐up (39 in the treatment group, 13 in the control group), scores on the Global Aesthetic Improvement Scale (GAIS) improved significantly in the treatment group at day 90 ± 7 (from 3.17 ± 0.39 to 2.97 ± 0.58), with no notable change in the control group. CMH chi‐square analysis revealed a significant difference in response rates (71.8%; 95% CI: 54.2%–89.4%). VISIA analysis showed significant improvements in spots, wrinkles, texture, and porphyrins (corrected p < 0.00625). Generalized estimating equation (GEE) modeling supported a time‐dependent cumulative effect. The treatment was well tolerated, with stable visual analogue scale (VAS) scores and no serious adverse events.

Conclusion

This preliminary study indicates that lyophilized rhCol III can significantly improve the appearance of the skin and is safe to use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin AgingRejuvenationCosmetic TechniquesCollagen Type IIIHumansFemaleMiddle AgedInjections, IntradermalFaceAdultMaleTreatment OutcomeRecombinant ProteinsFollow-Up StudiesAged

Stichwörter der Autor:innen

clinical trialinjectable aestheticrecombinant humanized type III collagenskin aging

Substanzen

Collagen Type IIIRecombinant Proteins

Autor:innen und Institutionen

  • Department of Dermatology, Changzhou First People's Hospital, Changzhou, China.
  • Department of Dermatology, The Second Affiliated Hospital of Wannan Medical College, Wuhu, China.

ORCID-Profile: Zeyu Huang, Ruzhi Zhang

Zitieren

APA

Huang, Z., Zhang, R., Sheng, M., Tian, T., Xu, B., Wang, F., & Liu, D. (2025). Translational Application of Recombinant Humanized Type III Collagen in Facial Rejuvenation: A Randomized Controlled Trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70529

Vancouver

Huang Z, Zhang R, Sheng M, Tian T, Xu B, Wang F, et al. Translational Application of Recombinant Humanized Type III Collagen in Facial Rejuvenation: A Randomized Controlled Trial. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70529

BibTeX
@article{Huang2025,
  author = {Huang, Zeyu and Zhang, Ruzhi and Sheng, Minmin and Tian, Ting and Xu, Bin and Wang, Fang and Liu, Danmin},
  title = {Translational Application of Recombinant Humanized Type III Collagen in Facial Rejuvenation: A Randomized Controlled Trial},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70529}
}
Kostenlos starten →